Red-light therapy’s strongest evidence is for cancer mouth sores, not wrinkles

Key takeaways

• Cancer experts in the 2019 MASCC/ISOO guideline recommend precise red-light protocols to help prevent painful mouth sores during some stem-cell transplants and head-and-neck radiation.
• Pooled across seven sham-controlled trials of home hair-loss devices, users grew more hair than people using look-alike fake devices, but no trial lasted longer than 26 weeks.
• Claims for wrinkles, muscle recovery and fat loss rest mostly on small, often company-funded studies, so treat them as promising but early at best.
• “FDA-cleared” usually means a device resembles one already on the market; the public summary for one cleared LED face mask listed bench tests, not clinical studies.
• Guard your eyes: in 2026, researchers found two red-laser devices sold for children’s nearsightedness could reach an eye-safety limit in under 3 seconds.

In a University of Houston lab, optometry researcher Lisa Ostrin and senior research scientist Alexander Schill tested four red-light devices sold to slow nearsightedness in children¹. JAMA Ophthalmology published their results in February 2026². In normal use, a child looks into the light for three minutes per session².

They measured how long each device took to reach a standard eye-safety limit, assuming a wide 7-millimeter pupil. The fastest got there in 1.4 seconds. A second took 2.8 seconds².

The university’s announcement of the study also cited a case reported by others. A 12-year-old suffered structural damage to the retina, the light-sensing layer at the back of the eye, and regained only part of the lost vision after stopping treatment¹.

That is one face of red-light therapy. The other face is stronger than many skeptics assume. Cancer specialists recommend carefully dosed red light to help prevent painful mouth sores during some treatments⁴.

Between those two facts sits a booming market of masks, caps, wands and wall panels. Here is what the research supports, and how to use a device without hurting your eyes or your wallet.

Red light works like a dose, not a color

Scientists call this field photobiomodulation. The term covers lasers, LEDs and other sources of red to near-infrared light used at low doses that don’t heat tissue⁴.

The leading theory starts in the mitochondria, the power plants inside your cells. An enzyme there, cytochrome c oxidase, absorbs red and near-infrared light³. One idea is that the light frees nitric oxide, a molecule that can stall the enzyme, so the cell makes more ATP, its energy currency³.

Treat that as a proposed mechanism. In a 2016 review, researchers Lucas de Freitas and Michael Hamblin wrote that the complete mechanism is still elusive³. Most of the ATP evidence comes from cell and animal studies³.

Wavelength matters. Devices mostly use red light of about 600 to 700 nanometers or near-infrared light of about 780 to 1,100 nanometers³. The band in between works less well because the enzyme absorbs less of it³.

Dose matters even more. Too little light does nothing, and too much can blunt or reverse the effect³⁴. Researchers call this a biphasic dose response. The cancer guideline authors call the precise dose critical⁴.

The best evidence comes from cancer wards, not spas

Oral mucositis means painful sores and inflammation in the mouth caused by cancer treatment. In 2019, the Multinational Association of Supportive Care in Cancer and the International Society of Oral Oncology (MASCC/ISOO) published a systematic review and clinical guidelines on light therapy for it⁴. A systematic review gathers and grades all the qualifying studies on one question.

The group recommended photobiomodulation to help prevent mouth sores in three settings⁴:

• stem-cell transplants that follow high-dose chemotherapy, with or without total-body radiation
• head-and-neck radiation therapy alone
• head-and-neck radiation combined with chemotherapy

Two of those three reached the guideline’s highest level of evidence⁴. The group could not make a recommendation for chemotherapy alone, for treating sores that had already formed, or for children⁴.

The protocols are exact. The recommended ones aim red light of 632.8 to 660 nanometers inside the mouth, at doses of 1.0 to 6.2 joules per square centimeter⁴. One transplant protocol shines laser light on 18 spots in the mouth for 40 seconds each⁴. The authors told clinicians to follow every setting and not to mix protocols⁴.

None of the randomized trials in the review reported side effects, either right away or later⁴. Still, the authors said long-term safety data are thin and advised care when treating any area where a tumor is present or suspected⁴. Three authors disclosed potential conflicts of interest, and the group said it expects its advice to change as new studies come in⁴.

So this is clinic treatment by trained staff, not proof that a home panel helps. If you have cancer, ask your oncology team before using any light device.

Home hair-loss devices: real regrowth, modest and short-term

Hair-loss lasers are the best-studied home use. The FDA cleared the first low-level laser device for male pattern hair loss in 2007, and by January 2020, 32 home-use devices were on the market⁶.

“Cleared” has a specific meaning. Through the FDA’s 510(k) process, a company shows its device is substantially equivalent to one already sold legally, a case that can rest on bench testing⁵.

A 2021 meta-analysis in the Journal of Clinical and Aesthetic Dermatology pooled seven double-blind randomized trials with 607 people⁶. In a randomized trial, people are assigned by chance to the real device or to a sham, a device that looks the same but doesn’t give the treatment light. Real-device users had greater hair density than sham users, in men and in women⁶.

One trial makes the size concrete. In a 2009 study of a laser comb in 110 men, users gained about 19.8 hairs per square centimeter over 26 weeks, while the sham group lost 7.6⁶.

Now the fine print:

• No trial ran past 26 weeks, so long-term benefit is unknown⁶.
• The trials enrolled only people with mild to moderate hair loss⁶.
• Laser-only devices did better than ones that mixed lasers with LEDs. Combs averaged bigger gains than helmets, but that gap could have been chance⁶.
• Only three trials reported light intensity, so devices are hard to compare⁶.
• Devices cost from $279 to $2,999⁶.

A 2024 trial of LED caps shows how messy this research can be. Of 160 people randomized, 91 were left out of the main analysis⁷. No single cap beat the sham on its own. Only when researchers pooled all the active caps did they find a gain of 28.5 hairs per square centimeter over sham⁷.

Wrinkles, muscles and fat: small studies, big claims

Skin is where red light is marketed hardest. The research is real but thin.

A 2014 trial in Photomedicine and Laser Surgery treated 113 people twice a week for 30 sessions⁸. Blinded raters judged wrinkles improved in 69% of the red-light group and 75% of a broadband-light group, compared with 4% of controls⁸. But the 23 controls, mostly employees of the sponsoring company, weren’t randomized and got no treatment. That company paid for the study and supplied the equipment⁸.

A 2021 review in Aesthetic Surgery Journal judged that a fair amount of trial evidence supports red and near-infrared light for skin aging, acne and hair loss. Body contouring, meaning slimming a targeted area of the body, looked best of all⁹. The same review flagged small groups, weak methods and industry funding, and said sales have grown faster than rigorous evidence⁹.

That review raised one more doubt: it’s unclear whether home LEDs match the lasers used in many of the better studies⁹. De Freitas and Hamblin, by contrast, wrote that LEDs can work as well as lasers³. Until head-to-head trials settle it, don’t assume a clinic laser result transfers to a home LED mask.

For weight loss, we found no trial showing that a home panel helps.

Muscle recovery is mixed. A 2022 meta-analysis in Sports Health pooled 24 trials in athletes¹⁰. Laser light before exercise improved leg strength in the following days and lowered soreness and creatine kinase, a blood marker of muscle damage¹⁰. Even so, the authors said a definite benefit had not been established and called for larger trials¹⁰.

An evidence map for red-light claims

This table uses four levels: strong evidence, promising but early, not enough evidence, and evidence says no (or unsafe).

Use	Evidence level	What the research shows
Preventing mouth sores in some cancer treatments	Strong evidence	Guideline recommends exact clinic protocols for transplant and head-and-neck radiation patients4
Treating existing mouth sores, or chemotherapy alone	Not enough evidence	Guideline group could not make a recommendation4
Modest regrowth within six months from laser combs and helmets	Strong evidence	Pooled data from seven double-blind trials in mild to moderate pattern hair loss favored real devices over sham6
Hair gains that last beyond six months	Not enough evidence	No trial followed users past 26 weeks6
LED caps for hair loss	Promising but early	Devices mixing LEDs with lasers did worse than laser-only ones; in a 2024 cap trial, no single cap beat sham67
Wrinkles and skin texture	Promising but early	Small trials, some without randomized controls, often company funded89
Muscle strength and soreness	Promising but early	24 laser trials found benefits; authors call the effect unproven10
Fat loss or slimming at home	Not enough evidence	A review rated clinic contouring well, with caveats; we found no home weight-loss trial9
Home red-laser treatment for children’s nearsightedness, as sold	Evidence says no, or unsafe	Asian trials reported slower progression, but two of four tested devices hit eye-safety limits within 3 seconds, and retinal injuries have been reported1212
“Cellular energy” and general wellness	Not enough evidence	The energy theory rests on cell and animal work3

Your eyes are the organ to protect

Red-light therapy for myopia, or nearsightedness, spread fast in Asia. A common design uses a 650-nanometer laser diode that a child looks into for three minutes, twice a day, five days a week¹². In clinical trials there, children’s myopia worsened more slowly and their eyes stretched less in length¹.

The University of Houston tests put names to the risk. The 1.4- and 2.8-second devices were lasers, Eyerising and Sky-n1201². A third took at least 253 seconds. An LED device, AirDoc, would take 22,761 seconds, more than six hours, but it had no published trials showing it works².

Eyerising has reportedly been used on more than 100,000 children in China¹. Writing in Optometric Management in 2023, Maria Liu said multiple cases of serious damage to the macula, the center of the retina, had been reported. She added that the trials’ main safety measure wasn’t sensitive enough to catch early damage¹².

China responded. From July 1, 2024, these devices needed Class III certification, which requires extensive safety testing, and approved use was limited to treating myopia in children 8 and older, not preventing it¹¹. Ophthalmology Times listed six countries that have approved Eyerising, including the United Kingdom, Japan and Australia. The United States was not on the list².

Adult devices carry eye risks too. The FDA’s January 2026 guidance on wellness products says a laser product claiming to rejuvenate skin is not low risk because “laser technology presents risks of skin and eye burns”¹³.

Wear the eye protection the maker supplies. Never look into a laser or bright LED source. Never buy a myopia device for a child outside an eye doctor’s care, and ask what independent safety testing it passed.

If your vision changes after using any light device, see an eye doctor promptly. Report injuries to the FDA’s MedWatch program.

What “FDA-cleared” tells you on a red-light device

Take one real example. In April 2023, the FDA cleared an LED face mask through the 510(k) route as a Class II over-the-counter device for wrinkles and mild to moderate inflammatory acne¹⁴.

Its wrinkle mode combined four wavelengths, from 605 to 880 nanometers, at a total of 70 milliwatts per square centimeter, for three minutes a session¹⁴. The public summary listed bench testing, including a photobiological safety standard called IEC 62471, and no clinical studies¹⁴.

That’s normal for a 510(k). It tells you the mask is similar to one already sold. It doesn’t tell you this mask was tested on faces.

The Federal Trade Commission polices the ads. In 2020, it settled with the sellers of the Willow Curve, a light device marketed for chronic pain¹⁵.

The FTC said the company falsely claimed the device treated severe pain and inflammation, was clinically proven and was FDA approved. It also said “risk free” refunds often weren’t paid¹⁵. The $22 million judgment was partly suspended after the owners each paid $200,000¹⁵.

A buyer’s checklist before you spend

Use these questions on any mask, cap, wand or panel.

1. What exactly is it cleared for? Ask for the 510(k) number and look up the cleared use. Wrinkles, acne or hair loss is not the same as pain, fat or “energy.”
2. Are the wavelength and power listed? You need both to estimate a dose. Look for red at 600 to 700 nm or near-infrared at 780 to 1,100 nm³.
3. Was this device tested against a sham? Ask for the study, not a testimonial. Check who paid for it⁸⁹.
4. Laser or LED? Many stronger trials used lasers⁹. A laser also raises the stakes for eye safety¹³.
5. What eye protection comes with it? Ask whether it was tested to a photobiological safety standard such as IEC 62471¹⁴.
6. Does the routine match the research? Hair trials mostly used sessions three to four times a week⁶. Doubling up isn’t proven to help.
7. Is there a written refund policy? Get it in writing, and keep the receipt.
8. Do you have cancer, or a child with myopia? Talk to your oncology team or eye doctor first¹⁴.

If an ad promises to cure pain, melt fat or fix disease, report it to the FTC at ReportFraud.ftc.gov.

Light is natural, and so is respecting its dose

Many natural-health readers already think about light as a nutrient: morning sun, darker evenings, time outdoors. Red-light research fits that instinct in one way. It works through the body’s own light-absorbing molecules, not a foreign drug⁴.

It also teaches the lesson herbalists know well. The right amount helps, and the wrong amount does nothing or harm³⁴. Respect for the body means respecting dose, wavelength and the eyes.

And it rewards healthy skepticism of every seller. The best evidence came from cancer teams following strict protocols⁴. The weakest came from studies funded by the companies selling the gear⁸⁹. Ask the same hard questions of a light panel that you would of a drug.

Questions readers ask

The bottom line

Red-light therapy is not a fad and not a cure-all. It has strong guideline support for preventing mouth sores in some cancer treatments and solid but modest, short-term results for laser hair-loss devices. Most claims for wrinkles, muscle recovery, fat and “cellular energy” rest on small or company-funded studies.

If you buy a device, read the dose, check what it’s cleared for, and protect your eyes every time. Keep red-light myopia devices away from children unless an eye doctor is managing the care, and talk to your oncology team before using light during cancer treatment.

Related reading

• “FDA registered” isn’t “FDA approved”: a buyer’s map to wellness devices
• Who paid for the study matters, even when the science is real
• Most health products aren’t scams, but many just haven’t been proven
• The famous sauna longevity study used Finnish saunas, not infrared cabins
• Six questions to ask before you buy anything for your health

Sources

1. University of Houston. “UH Professor Warns of Dangers of Red-Light Laser Myopia Therapy for Children.” University of Houston, 2026. uh.edu
2. Ophthalmology Times. “Commercial Red Light Devices for Myopia May Exceed Safety Limits.” Ophthalmology Times, 2026. ophthalmologytimes.com
3. de Freitas LF, Hamblin MR. “Proposed Mechanisms of Photobiomodulation or Low-Level Light Therapy.” IEEE Journal of Selected Topics in Quantum Electronics, 2016. pmc.ncbi.nlm.nih.gov
4. Zadik Y, Arany PR, Fregnani ER, et al. “Systematic Review of Photobiomodulation for the Management of Oral Mucositis in Cancer Patients and Clinical Practice Guidelines.” Supportive Care in Cancer, 2019. iris.unibs.it
5. U.S. Food and Drug Administration. “Premarket Notification 510(k).” FDA. fda.gov
6. Lueangarun S, Visutjindaporn P, Parcharoen Y, Jamparuang P, Tempark T. “A Systematic Review and Meta-analysis of Randomized Controlled Trials of United States Food and Drug Administration-Approved, Home-use, Low-Level Light/Laser Therapy Devices for Pattern Hair Loss.” Journal of Clinical and Aesthetic Dermatology, 2021. jcadonline.com
7. Thomas M, Stockslager M, Oakley J, Womble TM, Sinclair R. “Clinical Safety and Efficacy of Dual Wavelength Low-Level Light Therapy in Androgenetic Alopecia: A Double-Blind Randomized Controlled Study.” Dermatologic Surgery, 2024. citedrive.com
8. Wunsch A, Matuschka K. “A Controlled Trial to Determine the Efficacy of Red and Near-Infrared Light Treatment in Patient Satisfaction, Reduction of Fine Lines, Wrinkles, Skin Roughness, and Intradermal Collagen Density Increase.” Photomedicine and Laser Surgery, 2014. pubmed.ncbi.nlm.nih.gov
9. Glass GE. “Photobiomodulation: The Clinical Applications of Low-Level Light Therapy.” Aesthetic Surgery Journal, 2021. academic.oup.com
10. Luo W-T, Lee C-J, Tam K-W, Huang T-W. “Effects of Low-Level Laser Therapy on Muscular Performance and Soreness Recovery in Athletes: A Meta-analysis of Randomized Controlled Trials.” Sports Health, 2022. pubmed.ncbi.nlm.nih.gov
11. Myopia Profile. “Tighter Regulation of RLRL Devices in China.” Myopia Profile. myopiaprofile.com
12. Optometric Management. “An Explanation of RLRL, and Questions About This New Type of Treatment.” Optometric Management, 2023. optometricmanagement.com
13. U.S. Food and Drug Administration. “General Wellness: Policy for Low Risk Devices.” FDA guidance, 2026. fda.gov
14. U.S. Food and Drug Administration. “510(k) Summary K230042: Q-Rejuvalight Pro Facewear.” FDA, 2023. accessdata.fda.gov
15. Federal Trade Commission. “FTC Puts an End to Deceptive Advertising of Light Therapy Device.” FTC, 2020. ftc.gov